Net loss of Parabolic Drugs reported to Rs 98.67 crore in the quarter ended March 2013 as against net profit of Rs 9.02 crore during the previous quarter ended March 2012. Sales declined 78.76% to Rs 56.50 crore in the quarter ended March 2013 as against Rs 266.05 crore during the previous quarter ended March 2012.
For the Audited full year,net loss reported to Rs 139.76 crore in the year ended March 2013 as against net profit of Rs 51.21 crore during the previous year ended March 2012. Sales declined 16.91% to Rs 761.36 crore in the year ended March 2013 as against Rs 916.34 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales56.50266.05 -79 761.36916.34 -17 OPM %-218.3413.87 -1674 -9.2217.62 -152 PBDT-140.0719.99 PL -139.9997.29 PL PBT-156.0012.21 PL -195.0266.44 PL NP-98.679.02 PL -139.7651.21 PL
Powered by Capital Market - Live News
